# Whitehawk Therapeutics, Inc.: Form SCHEDULE 13D/A, filed May 14, 2026

- Company: [Whitehawk Therapeutics, Inc.](/companies/whwk.md) (CIK 1422142)
- Form: SCHEDULE 13D/A
- Filed: 2026-05-14
- Accepted by EDGAR: May 14, 2026, 20:04 ET
- Period: not reported
- Accession: 0000902664-26-002450
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1422142/000090266426002450/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1422142/000090266426002450/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1422142/000090266426002450/xslSCHEDULE_13D_X02/primary_doc.xml

Filed May 14, 2026.
Source: SEC EDGAR, the filing index for accession 0000902664-26-002450. Last ingested by Listed: Oct 24, 2026, 15:09 ET. No prices; not investment advice.